- Report
- December 2021
- 123 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- February 2024
- 121 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- April 2022
- 124 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2025
- 70 Pages
Argentina
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 219 Pages
Germany
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 130 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
India
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 150 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 130 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 110 Pages
Canada
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 90 Pages
Australia
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 100 Pages
North America
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2022
- 100 Pages
North America
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2022
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2020
- 114 Pages
Asia Pacific
From €3293EUR$3,450USD£2,759GBP
- Report
- June 2023
- 114 Pages
North America
From €2815EUR$2,950USD£2,359GBP
- Report
- June 2023
- 126 Pages
Europe
From €3293EUR$3,450USD£2,759GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more